Tocqueville Asset Management’s PDL BioPharma, Inc. PDLI Stock Holding History

Tocqueville Asset Management’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-28,853	Closed	-$98K	–	853
2017 Q3	$98K	Buy	+28,853	New	+$80.2K	﹤0.01%	795
2016 Q1	–	Sell	-17,956	Closed	-$64K	–	963
2015 Q4	$64K	Buy	17,956 +508	+3%	+$2.13K	﹤0.01%	890
2015 Q3	$88K	Buy	+17,448	New	+$100K	﹤0.01%	928
2014 Q2	–	Sell	-191	Closed	-$2K	–	1893
2014 Q1	$2K	Hold	191	–	–	﹤0.01%	1282
2013 Q4	$2K	Buy	+191	New	+$1.61K	﹤0.01%	1304
2013 Q3	–	Sell	-11,922	Closed	-$92K	–	980
2013 Q2	$92K	Buy	+11,922	New	+$93K	﹤0.01%	907

Other funds holding PDLI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Acadian Asset Management

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Mackenzie Financial

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return